Diagnostics and Tools

Supporting the Innovators who Optimize Therapeutic Decision-Making

Crosstree’s experience in the diagnostics and tools space is extensive, spanning routine chemistries to the most esoteric of testing, via either a product or service commercial approach. Molecular biology is reshaping the competitive landscape and Crosstree is at the forefront, facilitating synergistic transactions for a range of innovators in genomic and genetic testing and development.

No other partner is so uniquely equipped to assess and align the capabilities of diagnostics and tools companies with current market demands.

diagnostics-tools-aud-chart
Click image to view larger

Bluebooks

Explore our industry-specific Bluebooks for comprehensive monthly coverage of M&A, recapitalization, and growth financing transactions, along with year-on-year comparisons. Subscribe to your relevant BlueBook for valuable insights today.

D&T - BlueBook
Latest Diagnostics and Tools Transactions
Grant Avenue Capital Recapitalizes CREO

Grant Avenue Capital Recapitalizes CREO

QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally

QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally

Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering

Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering

Access Medical Labs Allies with Grupo Diagnostico Aries to Expand Diagnostic Lab Capabilities into North America

Access Medical Labs Allies with Grupo Diagnostico Aries to Expand Diagnostic Lab Capabilities into North America

Grenova Completes Growth Recapitalization with Peloton Equity to Accelerate Strategic Objectives

Grenova Completes Growth Recapitalization with Peloton Equity to Accelerate Strategic Objectives

PreventionGenetics acquired by Exact Sciences to Enable Earlier Cancer Detection and Hereditary Cancer Testing

PreventionGenetics acquired by Exact Sciences to Enable Earlier Cancer Detection and Hereditary Cancer Testing

ZebraSci Acquired by BD to Enhance Combination Product Testing Capabilities

ZebraSci Acquired by BD to Enhance Combination Product Testing Capabilities

Pyxant Labs Receives Majority Investment from ArchiMed

Pyxant Labs Receives Majority Investment from ArchiMed

Pyxant Labs Bolsters Capabilities in Acquisition of Covance by Labcorp’s SLC Bioanalytical Site

Pyxant Labs Bolsters Capabilities in Acquisition of Covance by Labcorp’s SLC Bioanalytical Site

Haematologic Technologies, Inc. was acquired by Edgewater Capital Partners

Haematologic Technologies, Inc. was acquired by Edgewater Capital Partners

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

HistoGeneX combines with Caprion Biosciences via strategic investment from Arsenal Capital Partners

HistoGeneX combines with Caprion Biosciences via strategic investment from Arsenal Capital Partners

MolecularMD has been acquired by ICON Plc.

MolecularMD has been acquired by ICON Plc.

Santus Laboratories (owned by HealthEdge Partners) sold Cough/Cold asset to Reliable1 – October 2018

Santus Laboratories (owned by HealthEdge Partners) sold Cough/Cold asset to Reliable1 – October 2018

Transposagen Biopharmaceuticals, Inc. has been acquired by Lonza

Transposagen Biopharmaceuticals, Inc. has been acquired by Lonza

PhenoPath has been acquired by Quest Diagnostics September 2018

PhenoPath has been acquired by Quest Diagnostics September 2018

Santus Laboratories (owned by HealthEdge Partners) was purchased by DermaRite (owned by Tailwind Capital Group) August 2018

Santus Laboratories (owned by HealthEdge Partners) was purchased by DermaRite (owned by Tailwind Capital Group) August 2018

OmniSeq Received a Strategic Investment from HITACHI April 12, 2018

OmniSeq Received a Strategic Investment from HITACHI April 12, 2018

MedLabs Diagnostics Recapitalized by Caymus Equity and PNC Mezzanine Capital April 3, 2018

MedLabs Diagnostics Recapitalized by Caymus Equity and PNC Mezzanine Capital April 3, 2018

Citoxlab acquired Solvo Biotechnology March 12, 2018

Citoxlab acquired Solvo Biotechnology March 12, 2018